Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study

Keyphrases

• Arthritis 100%
• Diabetes 100%
• Comorbidity 100%
• Colorectal Cancer 100%
• Nested Case-control Study 100%
• Colorectal Cancer Screening 100%
• Screening Marker 100%
• Blood-based 100%
• Demographic Characteristics 50%
• Single Marker 50%
• DNA Markers 50%
• DNA Methylation (DNAm) 50%
• Cancer Mortality 50%
• Overall Sensitivity 50%
• QPCR Assay 50%
• Tumor Stage 50%
• Commercially Available 50%
• Arteriosclerosis 50%
• Tumor Site 50%
• False-negative Results 50%
• Colorectal Cancer Staging 50%
• Case-control Study Design 50%
• Cancer-related Symptoms 50%
• Diagnostic Colonoscopy 50%
• Clinical Sensitivity 50%
• Wider Impacts 50%
• Methylation Assay 50%

Medicine and Dentistry

• Diabetes 100%
• Arthritis 100%
• Case-Control Study 100%
• Colorectal Cancer 100%
• Colorectal Cancer Screening 100%
• Malignant Neoplasm 66%
• Cancer Staging 66%
• Colonoscopy 33%
• Diagnosis 33%
• Symptom 33%
• Neoplasm 33%
• Polymerase Chain Reaction 33%
• False Positive Result 33%
• False Negative Result 33%
• Demography 33%
• Arteriosclerosis 33%
• DNA Methylation Assay 33%
• DNA Marker 33%